SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001412292-10-000006
Filing Date
2010-12-09
Accepted
2010-12-09 10:09:07
Documents
2
Period of Report
2007-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3/A  
1 PRIMARY DOCUMENT primary_doc.xml 3/A 1752
2 POA poadarazsdi.txt EX-24 3494
  Complete submission text file 0001412292-10-000006.txt   7076
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O PHARMACEUTICAL PRODUCT DEVELOPMENT 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address
Darazsdi Daniel G (Reporting) CIK: 0001412292 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-27570 | Film No.: 101241357